Cancer prevention before cancer treatment: understanding HPV, hepatitis B and the new “cancer vaccines” you may hear about in the news
1. Doctor, is there really a vaccine that can prevent cancer?
Yes—but only certain cancers can currently be prevented through vaccination.
The two important examples are:
HPV vaccine → helps prevent several cancers caused by human papillomavirus, especially cervical cancer.
Hepatitis B vaccine → prevents hepatitis B infection and thereby reduces the risk of hepatitis-B-related liver cancer.
These vaccines do not directly attack cancer cells. They prevent infections that can eventually cause cancer .
2. Then what are the new “cancer vaccines” I keep hearing about?
The term cancer vaccine is actually used for two very different things.
Cancer-PREVENTION vaccines
These are given to healthy people to prevent infections capable of causing cancer.
Important examples are the HPV vaccine and hepatitis B vaccine .
Cancer-TREATMENT vaccines
These are designed to stimulate the immune system against a cancer that has already developed.
Researchers are studying several approaches, including personalized and neoantigen cancer vaccines .
So whenever you read:
“Scientists have developed a new cancer vaccine!”
ask:
“Is this a vaccine that PREVENTS cancer, or a vaccine being studied to TREAT existing cancer?”
The two are very different.
HPV VACCINATION
3. What exactly is HPV?
HPV stands for human papillomavirus.
HPV infection is extremely common. Most infections disappear naturally, but persistent infection with certain high-risk HPV types can eventually lead to cancer.
HPV can contribute to cancers of the:
Cervix
Anus
Vulva
Vagina
Penis
Oropharynx/throat
So the HPV vaccine should not simply be thought of as a “cervical cancer vaccine for girls.”
It is a vaccine against an infection capable of causing several cancers.
4. Why is the HPV vaccine given at such a young age?
Because a preventive vaccine works best before exposure to the infection.
Girls approximately 9–14 years of age are therefore a major priority group for HPV vaccination.
Vaccinating a child against HPV does not mean that anyone is assuming that she is sexually active.
Think of it like wearing a seat belt.
You do not wait for an accident before putting it on.
Similarly, the best opportunity to prevent HPV infection is before future exposure occurs .
5. My budget is limited. Is HPV vaccination still worth considering?
For an unvaccinated young girl, particularly around 9–14 years of age, HPV vaccination can be a valuable preventive health investment.
But healthcare spending should always be considered sensibly.
If vaccination can be afforded without sacrificing essential food, education, necessary medicines or treatment of an existing illness , it is reasonable to consider it.
Preventive medicine should not mean financially exhausting a family to purchase every intervention available.
The objective is to spend healthcare resources where the expected benefit is meaningful.
6. Do I need to buy the most expensive HPV vaccine?
Not necessarily. More expensive does not automatically mean necessary for every person.
Different HPV vaccines protect against different numbers of HPV types, but established HPV vaccines target important cancer-causing HPV types, particularly HPV 16 and 18 .
Instead of asking:
“Which is the most expensive vaccine?”
ask:
“Which appropriate and approved vaccine can I realistically complete?”
If one particular brand appears unaffordable, discuss the available vaccine options, age indications and schedule with your doctor before abandoning vaccination altogether.
7. How many doses of HPV vaccine are required?
The schedule depends on age, immune status, national recommendations and sometimes the vaccine product being used.
This is one reason you may hear apparently different recommendations from different doctors, countries or health organizations.
Depending on the applicable guideline, HPV vaccination may involve one, two or three doses . People who are immunocompromised may require a different schedule.
Therefore, do not choose your dose schedule from a social-media post.
Ask your doctor which current guideline and schedule applies to you .
8. I am already married. Is it too late to take the HPV vaccine?
Not necessarily.
HPV vaccination prevents new HPV infections . It does not eliminate an infection that has already occurred.
Even someone previously exposed to HPV may not have encountered every HPV type covered by the vaccine.
However, the expected additional benefit generally becomes smaller as previous HPV exposure becomes more likely.
Vaccination is therefore most valuable before exposure .
In adults beyond the routine catch-up age, the decision may become more individualized depending on age, previous vaccination, future likelihood of HPV exposure and local recommendations.
This becomes particularly relevant if you are paying privately.
Instead of simply being told:
“Everyone must take it.”
ask:
“At my age and risk profile, how much additional benefit am I likely to receive?”
9. I already tested positive for HPV. Will the vaccine cure the infection?
No.
Preventive HPV vaccines do not treat an established HPV infection .
They also do not treat:
An abnormal Pap smear
Established cervical precancer
Cervical cancer
If your HPV test, Pap smear or cervical examination is abnormal, you still need the appropriate follow-up.
Do not postpone investigation or treatment hoping that vaccination will make an existing abnormality disappear.
10. If I take the HPV vaccine, can I stop cervical cancer screening?
No. Vaccination does not replace cervical screening.
Cancer prevention works through several layers:
HPV vaccination → cervical screening → detection and treatment of precancer → early cancer diagnosis → appropriate treatment
The HPV vaccine dramatically improves prevention, but it does not prevent every possible cervical cancer.
Follow the cervical screening recommendations appropriate for your age and circumstances even if you have been vaccinated.
11. What about HPV vaccination for boys and men?
Boys and men can also benefit from HPV vaccination.
HPV can cause cancers in males, particularly:
Oropharyngeal cancer
Anal cancer
Penile cancer
Vaccinating males can also reduce HPV transmission.
However, when governments or families have limited resources, public-health programs may prioritize particular age groups—especially young adolescent girls—because preventing cervical cancer remains a major global public-health objective.
Individual recommendations can therefore differ from population-level vaccination priorities.
HEPATITIS B AND LIVER CANCER
12. Is the hepatitis B vaccine also a cancer-prevention vaccine?
Yes. In an important sense, it is.
Many people think of hepatitis B vaccination simply as protection against hepatitis or jaundice.
Its long-term importance goes much further.
Chronic hepatitis B infection can lead to:
Chronic liver infection → cirrhosis → hepatocellular carcinoma (liver cancer)
Preventing hepatitis B infection therefore reduces an important cause of liver cancer.
This is one reason hepatitis B vaccination during childhood has such substantial long-term public-health value.
NEW AND PERSONALIZED CANCER VACCINES
13. What are personalized cancer vaccines?
These are treatment vaccines , not the routine preventive vaccines described above.
Researchers can analyse an individual patient's tumour and identify abnormal proteins or mutations that may be recognizable by the immune system.
In simplified terms:
Tumour analysed → abnormal targets identified → personalized vaccine designed → immune system trained to recognize tumour targets
These targets may include neoantigens —abnormal proteins arising from mutations within cancer cells.
This is an active and promising field of oncology research.
14. Have personalized cancer vaccines actually worked?
Some clinical trials have produced encouraging results, but “promising” does not mean “proven for every cancer.”
Personalized and neoantigen vaccines are being investigated in multiple malignancies, sometimes in combination with established immunotherapies.
Researchers have reported encouraging immune responses and clinical signals in selected cancers.
However, many of these approaches remain investigational , and important questions remain regarding which patients benefit, how long the benefit lasts, optimal combinations, manufacturing time and cost.
15. Are any cancer-treatment vaccines already used in medicine?
Yes, but only in specific situations.
One established example is sipuleucel-T , an autologous cellular immunotherapy used for selected patients with advanced prostate cancer.
Its existence does not mean that there is currently a therapeutic vaccine suitable for every cancer.
Different cancers behave differently and require different treatment strategies.
16. I already have cancer. Can I take a cancer vaccine instead of surgery, chemotherapy or radiotherapy?
Usually, no.
For most cancers today, experimental personalized cancer vaccines should not be regarded as substitutes for established treatments such as:
Surgery
Radiotherapy
Chemotherapy
Hormonal therapy
Targeted therapy
Established immunotherapy
If a cancer vaccine is being investigated for your disease, it may be available only through particular centres or clinical trials, sometimes alongside standard treatment.
Do not delay a proven curative treatment while waiting for an experimental vaccine because of an impressive headline or social-media claim.
17. How can I tell whether an advertised “cancer vaccine” is genuine?
Before paying, ask:
Is it meant to prevent cancer or treat an existing cancer?
Is it approved for my age, condition or cancer type?
Is it recommended by recognized medical/public-health guidelines?
If it is experimental, is it being offered through a properly registered clinical trial?
What evidence shows that it improves clinically meaningful outcomes?
Be particularly cautious if someone claims that one injection can prevent or cure all cancers .
There is currently no universal vaccine that does this.
COST AND DECISION-MAKING
18. So, should I spend money on a “cancer vaccine”?
Sometimes yes—but first establish exactly what you are paying for.
Before spending money, ask:
Is this intervention established or experimental?
What cancer or infection does it actually prevent or treat?
What is my age?
Have I likely already been exposed to the infection?
Does my immune status affect the schedule?
What do current guidelines recommend for someone like me?
Is there a less expensive appropriate vaccine option?
How large is my expected benefit compared with the cost?
This matters particularly when healthcare expenses come directly from family savings.
Good medical care does not mean purchasing every available medical intervention.
It means choosing interventions with meaningful evidence and applying them to the right person, at the right age and at the right level of risk .
19. What should I remember from all of this?
Four points are particularly important.
1. HPV vaccination can prevent cancer.
It substantially reduces the risk of several HPV-related cancers, particularly cervical cancer.
2. Timing matters.
The greatest preventive opportunity occurs when HPV vaccination is given before exposure to HPV, which is why vaccination at a young age is prioritized.
3. Hepatitis B vaccination also contributes to cancer prevention.
By preventing hepatitis B infection, it reduces an important cause of chronic liver disease and liver cancer.
4. New personalized cancer vaccines are different.
They represent an important and rapidly developing area of cancer treatment research, but most are not yet routine substitutes for established cancer treatments .
The Bottom Line
Vaccination is one part of cancer prevention.
It works alongside:
avoiding tobacco + maintaining a healthy lifestyle + appropriate vaccination + recommended cancer screening + recognizing warning symptoms + timely medical care
And when money is limited, remember:
You do not necessarily need the most expensive intervention.
You need the right intervention, for the right person, at the right time, based on reliable evidence.
That is what makes preventive medicine valuable.